Thus, 26.8 ± 1.8% of cells of high-grade GATA3-positive relapsed bladder cancer expressed CD8+; in low-grade tumors, 21.7 ± 1.5% of cells represented stromal immune microenvironment. This evidence concerns the gene CD8A and urinary bladder cancer.